Tenaya Therapeutics partners on parent attitudes survey for gene therapy in pediatric cardiomyopathy

Traders Union
All News
Business & Wealth
Companies
Tenaya surveys gene therapy views

Top Stories

Editors' Picks

Stocks

Crypto

Economics

Currencies

Commodities

Business & Wealth

Market Voices

13.05.2026

Tenaya Therapeutics partners on parent attitudes survey for gene therapy in pediatric cardiomyopathy — Tenaya surveys gene therapy views

Tenaya Therapeutics has joined forces with prominent pediatric advocacy group CCFheartkids and treatment center DdccLinic to conduct a survey among parents of children with cardiomyopathy regarding their views on gene therapy.

The findings from this survey were presented at the ASGCTherapy conference yesterday. This collaboration aims to capture the concerns and expectations of families affected by this rare condition and support the advancement of gene therapies in pediatric care.

View post on X Loading...

The tweet was deleted by the author.

But we saved everything 🙂.

Tenaya Therapeutics recently presented new clinical data from its RIDGE-1 Phase 1b/2 TN-401 trial in a late breaking session at ASGCT. The company has also recognized the contributions of Eugene Braunwald to hypertrophic cardiomyopathy and cardiology research in a recent tribute honoring his legacy. These initiatives emphasize Tenaya's continued engagement in advancing cardiomyopathy research and therapies.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.

Did you like the article?

#Tenaya

Editor's Picks for You

From Coinbase to Visa: Who makes money from blockchain?

By Anastasiia Chabaniuk
11 hours ago

From Coinbase to Visa: Who makes money from blockchain?

Editors' Picks

One of the biggest M&A deals: Why is Marvell buying Lumentum?

By Mikhail Vnuchkov
12 hours ago

One of the biggest M&A deals: Why is Marvell buying Lumentum?

Editors' Picks

By Olena Litvinenko
Yesterday

Not Satoshi: Who created Bitcoin’s logo?

Editors' Picks

All Editors' Top Picks

Latest Tenaya News

Tenaya Therapeutics unveils second quarter financial results and updates on business programs

By Ashutosh Sureka
06.08.2026

Tenaya Therapeutics unveils second quarter financial results and updates on business programs

Companies

Tenaya Therapeutics sees advances in symptom relief and cardiac hypertrophy measures

By Andreas Kristo
03.06.2026

Tenaya Therapeutics sees advances in symptom relief and cardiac hypertrophy measures

Companies

Tenaya Therapeutics CEO to present at Jefferies Global Healthcare Conference on June 4

By Eugene Komchuk
29.05.2026

Tenaya Therapeutics CEO to present at Jefferies Global Healthcare Conference on June 4

Companies

All Tenaya News

Anastasiia Chabaniuk
11 hours ago

From Coinbase to Visa: Who makes money from blockchain?

Mikhail Vnuchkov
12 hours ago

One of the biggest M&A deals: Why is Marvell buying Lumentum?

Olena Litvinenko
Yesterday

Not Satoshi: Who created Bitcoin’s logo?

Eugene Komchuk
Yesterday

Ryanair tightens its belt: How rising fuel prices threaten the budget airline

Dmytro Kharkov
Yesterday

How German metalworkers’ strikes are testing Europe’s industrial strength

Mykhailo Ihnatenko
15 min ago

Steve Burns: S&P 500 index performance after U.S. midterm elections questioned

Igor Krasulya
20 min ago

Corporate America sees inflation rise in earnings discussions, Scott Lincicome notes

Alena Volkova
30 min ago

Liquidation of my bank was mishandled, Peter Schiff says

Hanna Syniavska
45 min ago

Recent U.S. housing gains prompt debate on investment value, Ben Carlson notes

Eugene Komchuk
1 hour ago

Tariffs can raise manufacturing investment costs by 8.7 percent, Kyle Pomerleau notes

Top News

Darina Pashchenko
6 hours ago

Binance reveals hack scheme involving fake job interviews and AI

Binance reveals hack scheme involving fake job interviews and AI

Olga Shendetskaya
8 hours ago

Oil prices slide as U.S.-Iran diplomacy gains momentum

Oil prices slide as U.S.-Iran diplomacy gains momentum

Eugene Komchuk
9 hours ago

China and Oman agree to cooperate on digital currencies

China and Oman agree to cooperate on digital currencies

Andrey Mastykin
11 hours ago

Apple shares fall as China revenue misses estimates

Apple shares fall as China revenue misses estimates

Ivan Andriyenko
12 hours ago

Turkey arrests stock exchange chief after fund collapse hits investors

Turkey arrests stock exchange chief after fund collapse hits investors

Top 5 companies for you

United States

Live News

Hanna Syniavska
Now

Trump signals progress on Canada trade deal amid tariff tensions

Kyle Torpey
Now

South Korea considers 99% cold storage rule for crypto exchanges

Anton Kharitonov
Now

EUR/USD retreats toward 1.1180 as U.S. data strengthens the dollar

Jose Antonio Gastelum
Now

French lawmakers reject taxes on unrealized crypto gains

Mykhailo Ihnatenko
Now

Nvidia stock forecast: Can 200-day SMA support a rebound toward $210?

© IAFT Ltd., 2010-2026 All rights to the website are owned by IAFT Ltd.,
Registration number - HE 336186

Risk disclosure:

Information on the TradersUnion.com website is for informational purposes only and does not constitute any motive or suggestion to visitors to invest money. Moreover, we hereby warn you that trading on the Forex and CFD markets is always a high risk. According to the statistics, 75-89% of customers lose the funds invested and only 11-25% of traders earn a profit. Trading in futures and options carries substantial risk of loss and is not suitable for every investor.

That is why you should only invest money that you are prepared — or can afford — to lose at such high risks. Tradersunion.com does not provide any financial services, including investment or financial advisory services. Also, the Traders Union is not a broker and does not get money for trading in the Forex or CFD markets. Our website only provides information on brokers and the markets and helps its users to select the best brokerage company based on detailed information and objective analysis of brokers.
Disclaimer:

Traders Union (TradersUnion.com) shall not be liable for the consequences of trading decisions made by the Client and for the possible loss of his capital resulting from the use of this website and information published on it.

Forex market, CFD and cryptocurrency trading involves high risks and is not suitable for everyone. Before investing money, you need to adequately assess the level of your expertise and be aware of the risks, particularly in the context of trading with leverage. The information on this website is not intended for distribution or use by any person in any country or jurisdiction, where such distribution or use would be in violation of the local law or regulation. Any payments by Traders Union (TradersUnion.com) to the users of our website shall be legally interpreted solely as an incentive on our part for the activity on the website in the form of a deduction of a part of the advertising income; they shall not be a subject of any claims of our users or our obligations, a subject of disputes, as well as cannot be considered in relation to the services provided to users by brokers, both in fact and in their completeness and volume. The administration of the website shall not be liable for the content of user comments and reviews about the companies and shall not verify whether the authors of the reviews are indeed real clients of a specific company. All reviews, both negative and positive are published on the website without verification of their reliability; only offensive reviews that call for violence or any kind of discrimination and also reviews published from one group of IP addresses are moderated and removed. The authors of the materials shall be fully liable for the accuracy, completeness and impartiality of any information in the articles and reviews, including in the context of their use or mention of any brand names or trademarks. All mentions of the names of companies and their brands in any materials on the website shall be made in the context of communication of socially important information to the people about their activities by independent journalists, who are the authors. All evaluations and indicators on the website express the subjective opinion of the authors of the reviews (articles) and shall not be viewed as accurate statements and be a subject of disputes and claims against Traders Union.
Disclosure of advertisers and revenues:

All the services on the Tradersunion.com website are free for you to use. Our team spends thousands of hours per annum researching brokers and gathering information about them to help investors all over the world to choose reliable companies and to avoid fraudsters.

Indeed, the curating, sourcing, and organization of this process requires substantial financial investment by Tradersunion.com, which the website earns in the form of advertising payments. There are two types of advertising services on the website — direct advertising or partner (broker) participation programs. However, no services purchased by our partners shall affect the recommendations on our website, or our opinions, or ratings. Our ratings are based on our objective rating criteria and methodology; and the results are always equally and fairly applied to each broker. The work of our content authors and research groups does not involve any interaction with our advertisers and they do not have access to data concerning the amount of advertising purchased. For over 10 years we consider our independence, absolute openness, and objectivity as our main priority. Please follow the links to each of our affiliated broker’s websites. This will help Tradersunion.com to continue to provide our services to you for free.